IGM Biosciences IGMS 深 滬
等待開盤 07-18 09:30:00 美东时间
1.275
+0.005
+0.39%
華盛通- 最 高1.29
- 今 開1.28
- 成交量 8.00万股
- 最 低 1.275
- 昨 收 1.27
- 總市值 7664.68万
- 52周最高 22.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.92
- 委 比 89.29%
- 總股本 6011.51万
- 歷史最高 133.00
- 量 比 0.20
- 振 幅 1.18%
- 歷史最低 0.92
- 每 手 1
- 風險率 5.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP
NEW YORK, July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
07-04 05:29
IGM Biosciences Announces Merger with Concentra Biosciences
IGM Biosciences ( ($IGMS) ) just unveiled an announcement. On July 1, 2025, IGM...
07-01 21:49
IGM Biosciences shares are trading higher after the company announced it will be acquired by Concentra Biosciences for $1.247 per share.
IGM Biosciences shares are trading higher after the company announced it will b...
07-01 21:24
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
<p>IGM Biosciences, Inc. has entered into a definitive merger agreement with Concentra Biosciences, LLC, under which Concentra will acquire IGM Biosciences for $1.247 per share in cash plus a non-tradeable contingent value right (CVR). The transaction is expected to close in August 2025, subject to certain conditions, including the tender of at least a majority of outstanding shares and the availability of $82 million in cash. IGM Biosciences' Bo...
07-01 12:58
美股大行评级 | 潜在涨幅超50%，数十家机构大幅上调甲骨文目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140203048973164544.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：上调Datavault AI(DVLT)评级至"买入"，目标价3美元</p> <p>• 蒙特利尔银行：维持DoubleVerify Holdings(DV)"跑赢大市"评级，目标价从25美元升至26
06-13 09:33
美股大行评级 | GitLab遭多家大行下调目标价！Stifel首予优步"买入"评级，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139839943846023169.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Loop Capital：维持Dave & Buster's Enter(PLAY)"买入"评级，目标价从35美元升至46美元</p> <p>• Stifel：维持嘉年华(CCL)"买入"评级，目标价从31美元升至
06-12 09:46
IGM Biosciences Faces Nasdaq Non-Compliance Notice
IGM Biosciences ( ($IGMS) ) has issued an update. On June 6, 2025, IGM Bioscien...
06-12 05:29
Truist Securities Maintains Hold on IGM Biosciences, Lowers Price Target to $1
Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price target from $2 to $1.
06-12 01:33
IGM Biosciences Reports Increased Net Loss Amid Strategic Focus
Igm Biosciences ( ($IGMS) ) has released its Q1 earnings. Here is a breakdown o...
06-03 11:51
